Timothy Schultheiss, Ph.D., director of radiation physics at City of Hope, has been selected as a fellow of the American Society for Therapeutic Radiology and Oncology (ASTRO).

ASTRO grants this distinction on members who have contributed significantly to ASTRO and to the field of radiation oncology over their career. He will be inducted as a fellow at ASTRO’s 49th Annual Meeting in Los Angeles, held from Oct. 28 to Nov. 1.

“Dr. Schultheiss has made numerous contributions to the field of radiation oncology,” said Jeffrey Wong, M.D., chair of the Division of Radiation Oncology. “This includes his role as one of the pioneers of 3-D treatment planning and conformal radiation therapy.”

Both through his own independent efforts and through partnerships with industry, Schultheiss was instrumental in making computed tomography simulation one of the mainstays of radiation therapy treatment planning, Wong added.

Schultheiss earned his doctorate in physics at Brown University and began his career at Eastern Virginia Medical School. He soon moved to M.D. Anderson Cancer Center, where he was recognized for his contributions to work related to spinal cord tolerance.

From 1991 to 2001, he was the director of radiation physics and professor in radiation oncology at Fox Chase Cancer Center, where he was recognized for significant contributions to the field of radiation therapy for prostate cancer.

He joined City of Hope and Beckman Research Institute as director of radiation physics in 2001.